Up to 151 days of continuous animal perfusion with trivial heparin infusion by the application of a long-term durable antithrombogenic coating to a combination of a seal-less centrifugal pump and a diffusion membrane oxygenator
We developed a new coating material (Toyobo-National Cardiovascular Center coating) for medical devices that delivers high antithrombogenicity and long-term durability. We applied this coating to an extracorporeal membrane oxygenation (ECMO) system, including the circuit tube, cannulae, a seal-less centrifugal pump, and a diffusion membrane oxygenator, to realize prolonged cardiopulmonary support with trivial anticoagulant infusion. The oxygenator consisted of a hollow-fiber membrane made of polymethylpentene, which allows the transfer of gas by diffusion through the membrane. The centrifugal pump was free of seals and had a pivot bearing. We performed a venoarterial bypass in a goat using this ECMO system, and the system was driven for 151 days with trivial anticoagulant infusion. Plasma leakage from the oxygenator did not occur and sufficient gas-exchange performance was well maintained. In the oxygenator, thrombus formation was present around the top and the distributor of the inlet portion and was very slight in the outlet portion. In the centrifugal blood pump, there was some wear in the female pivot region and quite small amounts of thrombus formation on the edge of the shroud; the pivot wear seemed to be the cause of the hemolysis observed after 20 weeks of perfusion and which resulted in the termination of the perfusion. However, no significant amounts of thrombus were observed in other parts of the system. This ECMO system showed potential for long-term cardiopulmonary support with minimal use of systemic anticoagulants.
Key wordsArtificial lung Antithrombogenicity Extracorporeal membrane oxygenation (ECMO)
Unable to display preview. Download preview PDF.
- 1.Nishinaka, T, Tatsumi, E, Taenaka, Y, Katagiri, N, Ohnishi, H, Shioya, K, Fukuda, T, Oshikawa, M, Sato, K, Tsukiya, T, Homma, A, Takewa, Y, Takano, H, Sato, M, Kashiwabara, S, Tanaka, H, Sakai, K, Matsuda, T 2002At least 34 days of animal continuous perfusion by a newly developed extracorporeal membrane oxygenation system without systemic anticoagulantsArtif Organs26548551PubMedCrossRefGoogle Scholar
- 3.Sato, M, Kashiwabara, S, Tanaka, H, Tatsumi, E, Taenaka, Y, Takano, H 1999In vitro antithrombogenic evaluation of newly developed heparinized materialJpn J Artif Organs28502508Google Scholar
- 4.Mizuno, T, Tatsumi, E, Nishinaka, T, Katagiri, N, Oshikawa, M, Naito, H, Shirakawa, Y, Tsukiya, T, Homma, A, Takewa, Y, Takano, H, Kitamura, S, Taenaka, Y 2003Observation of alveolar fibrosis in a goat following venoarterial bypass for up to 5 months using extracorporeal membrane oxygenationJ Artif Organs7107109Google Scholar